RECENT NEWS
MarketWatch  Apr 4  Comment 
CVS Health Corp. said Wednesday it was launching a new initiative to focused on chronic kidney disease, including early identification of kidney disease and the expansion of home dialysis. As part of the home dialysis program, CVS will initiate a...
The Hindu Business Line  Mar 1  Comment 
The upsurge in kidney ailment cases in Tamil Nadu over the last five years has prompted dialysis centre network – Nephroplus – to focus on strengthening its presence in the state. In associ
MedPage Today  Feb 22  Comment 
(MedPage Today) -- Children and adolescents on dialysis had lowest scores, systematic review found
The Hindu Business Line  Feb 21  Comment 
Philips Home Care Services, a subsidiary of Dutch giant Philips, will launch home chemo and dialysis services in India by March. The services will be launched in select cities initially. Add
New York Times  Feb 17  Comment 
More than 200 patients were evacuated to the mainland United States when hurricanes blasted their islands last fall. Many are still in Atlanta, unable to go home safely.
Motley Fool  Jan 24  Comment 
Could Cara be the answer for investors itching to make $1 million?
The Hindu Business Line  Jan 12  Comment 
Dialysis service provider NephroPlus is set to begin its international journey in 2018. It is firming up its first venture in one of the developing countries in South Asia, Africa or West Asia. Hav...
Cellular News  Nov 7  Comment 
Baxter International Inc. (NYSE:BAX), a global innovator in renal care, presented new data on SHARESOURCE, the company's remote patient management platform, indicating the potential value of this telehealth platform to improve...
Benzinga  Nov 6  Comment 
Keryx Biopharmaceuticals (NASDAQ: KERX) shares are trading lower by $0.16 at $6.21 in Monday's session. At this time, investors aren't that impressed with the company's presentation of the positive real world dialysis data of Auryzia presented...
GenEng News  Nov 2  Comment 
University of Minnesota scientists say they have created a lab-grown blood vessel replacement composed of biological materials, but without living cells at implantation. The vessel, which could be used as an off-the-shelf graft for kidney...




RELATED WIKI ARTICLES
 

Companies in this industry provide dialysis services to patients with diabetes. These companies make a substantial portion of their revenue from prescribing diabetes drugs. They also heavily dependent on Medicare and Medicaid.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki